Mode
Text Size
Log in / Sign up

Higher Red Cell Distribution Width to Albumin Ratio (RAR) associated with increased mortality in pulmonary sepsisHigh RAR linked to higher death risk in pulmonary sepsis patients

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Consider RAR as a potential prognostic marker in pulmonary sepsis, pending prospective validation.

This retrospective study with dual-cohort validation analyzed 6,065 patients with sepsis secondary to pulmonary infections from Binzhou Medical University Hospital and the MIMIC-IV database. It examined the association between the Red Cell Distribution Width to Albumin Ratio (RAR) and 28-day ICU and in-hospital mortality, comparing outcomes between high and low RAR groups.

For each unit increase in RAR, the hazard ratio (HR) for 28-day ICU mortality was 1.52 (95% CI: 1.28–1.80). For 28-day in-hospital mortality, the HR was 1.30 per unit increase (95% CI: 1.09–1.55). When analyzed categorically, the high RAR group had an HR of 1.45 for ICU mortality (95% CI: 1.23–1.70) and an HR of 1.29 for in-hospital mortality (95% CI: 1.09–1.52) compared to the low RAR group.

Safety and tolerability data were not reported. The study's key limitation is its retrospective design; the authors note that prospective validation is warranted to confirm the utility of RAR for risk stratification in this population. The findings were consistently validated in the external cohort.

In practice, the RAR-based scoring system shows promise as a practical adjunct tool for clinical risk assessment. However, clinicians should interpret these findings as demonstrating a significant association, not causation, and await prospective confirmation before implementing RAR in routine prognostic decision-making.

Researchers analyzed data from over 6,000 patients who had severe infections in their lungs. They calculated a score called the Red Cell Distribution Width to Albumin Ratio, or RAR, for each person. This score combines two common blood test results to see if it could help predict who might be at higher risk of dying soon after admission.

The study found a clear link between higher RAR scores and worse outcomes. Patients with higher RAR levels had a significantly greater chance of dying within 28 days compared to those with lower scores. This association held true whether looking at ICU deaths or deaths in the hospital overall.

No safety issues were reported because the study only looked at existing records and did not test a new treatment. The main reason to be careful is that this was a retrospective study, meaning doctors looked back at past data rather than following patients forward in time. While the results are consistent across different data sets, experts say prospective validation is needed to confirm this tool works for improving risk assessment in real-world settings.

Readers should understand that this finding suggests a link but does not prove that changing the RAR score will change patient outcomes. The study shows promise as a potential tool for risk assessment, but it is not yet ready to replace current methods for judging patient risk.

What this means for you:
Higher RAR scores linked to higher death risk in lung infection patients; more research needed.

Study Details

Study typeCohort
EvidenceLevel 3
PublishedApr 2026
View Original Abstract ↓
The Red Cell Distribution Width to Albumin Ratio (RAR) is a biomarker that reflects a patient’s nutritional status, inflammatory response, and oxidative stress, showing significant potential in critical care medicine. To investigate its prognostic value, we conducted a retrospective study using a dual-cohort design to assess the association between RAR and short-term (28-day) mortality in patients with pulmonary sepsis. We retrospectively identified patients with sepsis secondary to pulmonary infections from the Binzhou Medical University Hospital medical records and the Medical Information Mart for Intensive Care (MIMIC-IV) database. To examine the association between RAR and short-term adverse outcomes in these patients, we employed several statistical methods, including Kaplan–Meier survival curves, multivariable Cox regression, and restricted cubic spline (RCS) analysis. Subsequently, we applied machine learning algorithms—namely the Boruta algorithm, LASSO-COX regression, and Random Forests—to identify the most predictive features. These features were then used to develop a final multivariable Cox regression model for risk prediction. The performance of this predictive model was evaluated using receiver operating characteristic (ROC) curve analysis. The final analysis included 6,065 patients with pulmonary sepsis. The 28-day ICU and in-hospital mortality rates were 20.50 and 19.30%, respectively. In the fully adjusted multivariable model, a higher RAR was significantly associated with increased 28-day ICU and in-hospital mortality, whether treated as a continuous or categorical variable. For each unit increase in the continuous RAR score, the hazard ratios (HR) for 28-day ICU and in-hospital mortality were 1.52 (95% CI: 1.28–1.80) and 1.30 (95% CI: 1.09–1.55), respectively. Similarly, when compared to the low RAR group, the high RAR group had hazard ratios of 1.45 (95% CI: 1.23–1.70) and 1.29 (95% CI: 1.09–1.52) for the two outcomes. The restricted cubic spline (RCS) analysis revealed a positive dose–response relationship between RAR levels and short-term adverse outcomes. Furthermore, the risk prediction model incorporating RAR and eight other independent predictors demonstrated superior performance in identifying high-risk patients compared to traditional critical illness scoring systems, as shown by receiver operating characteristic (ROC) analysis. All findings were consistently validated in the external cohort. In conclusion, our study demonstrates a significant inverse association between the RAR and short-term survival in patients with severe pulmonary sepsis. The RAR-based scoring system we developed shows promise as a practical adjunct tool for clinical risk assessment. Prospective validation is warranted to confirm its utility in improving risk stratification for this patient population.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.